NO20055243L - Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) - Google Patents
Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)Info
- Publication number
- NO20055243L NO20055243L NO20055243A NO20055243A NO20055243L NO 20055243 L NO20055243 L NO 20055243L NO 20055243 A NO20055243 A NO 20055243A NO 20055243 A NO20055243 A NO 20055243A NO 20055243 L NO20055243 L NO 20055243L
- Authority
- NO
- Norway
- Prior art keywords
- sars
- acute respiratory
- respiratory syndrome
- severe acute
- interferon beta
- Prior art date
Links
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 title abstract 4
- 102000003996 Interferon-beta Human genes 0.000 title 1
- 108090000467 Interferon-beta Proteins 0.000 title 1
- 229960001388 interferon-beta Drugs 0.000 title 1
- 102000014150 Interferons Human genes 0.000 abstract 2
- 108010050904 Interferons Proteins 0.000 abstract 2
- 229940079322 interferon Drugs 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Anvendelse av et interferon (IFN) til fremstilling av et legemiddel som er nyttig for behandling og/eller forhindring av alvorlig akutt respiratorisk syndrom (SÅRS) er beskrevet i den foreliggende oppfirmelse.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101066 | 2003-04-17 | ||
| PCT/EP2004/050456 WO2004091653A1 (en) | 2003-04-17 | 2004-04-06 | Interferon beta in severe acute respiratory syndrome (sars) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055243L true NO20055243L (no) | 2005-11-08 |
Family
ID=33185950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055243A NO20055243L (no) | 2003-04-17 | 2005-11-08 | Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070026014A1 (no) |
| EP (1) | EP1613342A1 (no) |
| JP (1) | JP2006523655A (no) |
| KR (1) | KR20050112127A (no) |
| CN (1) | CN1798572A (no) |
| AU (1) | AU2004229185A1 (no) |
| BR (1) | BRPI0409484A (no) |
| CA (1) | CA2521650A1 (no) |
| EA (1) | EA008766B1 (no) |
| MX (1) | MXPA05011170A (no) |
| NO (1) | NO20055243L (no) |
| UA (1) | UA81481C2 (no) |
| WO (1) | WO2004091653A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006528679A (ja) * | 2003-04-01 | 2006-12-21 | インターミューン インコーポレイテッド | コロナウイルス感染症及びサースを治療するための組成物及び方法 |
| EP1641485A4 (en) * | 2003-06-09 | 2009-06-24 | Genome Inst Of Singapore | INHIBITION OF SARS CORONAVIRUS INFECTION USING ANTIVIRAL DRUGS CLINICALLY TESTED |
| US9295669B2 (en) | 2010-12-14 | 2016-03-29 | Hoffman La-Roche Inc. | Combination therapy for proliferative disorders |
| CN115867288A (zh) * | 2020-03-27 | 2023-03-28 | 维克多瑞有限公司 | 用于治疗呼吸系统病症的组合物 |
| US20220125661A1 (en) * | 2020-10-22 | 2022-04-28 | Jacob Waterman | Patient-Worn Therapeutic Apparatus |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| BR9910505A (pt) * | 1998-05-15 | 2001-01-02 | Schering Corp | Terapia de combinação compreendendo ribavirina e interferon alfa em pacientes cândidos de tratamento antiviral tendo infecção crÈnica por hepatite c |
| JP2002220343A (ja) * | 2001-01-26 | 2002-08-09 | Toray Ind Inc | びまん性肺疾患延命剤 |
| US20030143199A1 (en) * | 2001-10-09 | 2003-07-31 | Carson Dennis A. | Use of STAT-6 inhibitors as therapeutic agents |
| US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
| WO2005009337A2 (en) * | 2003-05-16 | 2005-02-03 | Hemispherx Biopharma | Treating severe acute respiratory syndrome |
-
2004
- 2004-04-06 AU AU2004229185A patent/AU2004229185A1/en not_active Abandoned
- 2004-04-06 KR KR1020057019312A patent/KR20050112127A/ko not_active Withdrawn
- 2004-04-06 CN CNA2004800146510A patent/CN1798572A/zh active Pending
- 2004-04-06 BR BRPI0409484-0A patent/BRPI0409484A/pt not_active IP Right Cessation
- 2004-04-06 WO PCT/EP2004/050456 patent/WO2004091653A1/en not_active Ceased
- 2004-04-06 CA CA002521650A patent/CA2521650A1/en not_active Abandoned
- 2004-04-06 MX MXPA05011170A patent/MXPA05011170A/es not_active Application Discontinuation
- 2004-04-06 EP EP04725948A patent/EP1613342A1/en not_active Withdrawn
- 2004-04-06 EA EA200501625A patent/EA008766B1/ru not_active IP Right Cessation
- 2004-04-06 JP JP2006505526A patent/JP2006523655A/ja active Pending
- 2004-04-06 US US10/553,135 patent/US20070026014A1/en not_active Abandoned
- 2004-06-04 UA UAA200510856A patent/UA81481C2/uk unknown
-
2005
- 2005-11-08 NO NO20055243A patent/NO20055243L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1798572A (zh) | 2006-07-05 |
| EP1613342A1 (en) | 2006-01-11 |
| EA200501625A1 (ru) | 2006-04-28 |
| KR20050112127A (ko) | 2005-11-29 |
| WO2004091653A1 (en) | 2004-10-28 |
| JP2006523655A (ja) | 2006-10-19 |
| AU2004229185A1 (en) | 2004-10-28 |
| BRPI0409484A (pt) | 2006-05-02 |
| US20070026014A1 (en) | 2007-02-01 |
| UA81481C2 (en) | 2008-01-10 |
| MXPA05011170A (es) | 2005-12-14 |
| CA2521650A1 (en) | 2004-10-28 |
| EA008766B1 (ru) | 2007-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05065B1 (et) | Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid | |
| NO20073632L (no) | Behandling av hepatitt C med interferon-beta i en asiatisk populasjon | |
| NO20006328D0 (no) | Attenuerte negative trådvirus med endret interferonantagonistaktivitet for anvendelse som vaksiner og medikamenter | |
| WO2005023290A3 (en) | Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections | |
| ATE476983T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege | |
| IL171972A0 (en) | Compositions and methods for treatment of severe acute respiratory syndrome(sars) | |
| BR0011433B1 (pt) | Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos | |
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| PL371736A1 (en) | Method for administering glp-1 molecules | |
| TW200733953A (en) | Materials and methods for treating viral infections | |
| NO20044272L (no) | Legemiddel for behandling og/eller forebyggelse av kronisk avstotning | |
| WO2005007078A3 (en) | Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars) | |
| DK1423168T3 (da) | Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse | |
| EP0652011A4 (en) | PROPHYLACTIC MEDICINE AND MEDICINAL PRODUCT FOR VIRAL DISEASES OF THE BREATHWAYS. | |
| NO20065860L (no) | Stabiliserte flytende interferonformuleringer | |
| EP1649053A4 (en) | CHARACTERIZATION OF THE EARLY LEVELS OF THE VIRUS OF HEAVY ACUTE RESPIRATORY SYNDROME (SARS) AND USES THEREOF | |
| TW200633995A (en) | Andrographolide derivatives to treat viral infections | |
| WO2004089983A3 (en) | Severe acute respiratory syndrome (sars) causing coronavirus | |
| NO20055243L (no) | Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) | |
| WO2022099187A3 (en) | Sars-cov-2 antigen-binding proteins and uses thereof | |
| BR9916893A (pt) | Tratamento | |
| NO20053348L (no) | Farmasoytisk sammensetning for behandling av virusangrep. | |
| WO2007057436A3 (en) | Interferon in influenza | |
| NO20055512L (no) | Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider | |
| AU2003298578A1 (en) | Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |